Germany's Merck in advanced talks to acquire US biotech firm SpringWorks
(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...
Exclusive-Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Medical Dialogues8h
Merck eyes SpringWorks Therapeutics in potential pharma deal
Merck KGaA, the German healthcare and technology conglomerate, has announced that it is in advanced negotiations to acquire ...
U.S. News & World Report8d
Merck 2025 Sales Forecast Underwhelms as It Pauses Gardasil Sales in China
New Jersey, company. For the recently completed fourth quarter, Merck booked an adjusted profit of $1.72 per share on $15.6 billion in revenue. Sales of top-selling cancer treatment Keytruda ...
Morningstar12d
Merck Receives Positive EU CHMP Opinion for CAPVAXIVEâ„¢ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults
Merck Research Laboratories. “This positive opinion is yet another testament to the clinical profile of CAPVAXIVE and brings us a step closer to helping protect adults in the EU against ...